Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs 2007)

Lim, Penny; Paver, Robert; Peñas, Pablo F.

doi:10.1016/j.jaad.2009.12.026

Cited by 16 publications

(16 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Most of the MMS series for NMSC show that 90–95% of the tumors treated with this procedure are BCC, whereas 5–10% are SCC . These data are consistent with our study.…”

Section: Discussionsupporting

confidence: 92%

“…In the SCC group, the predominant types of closures were linear closure and flaps. We have found that the use of grafts and second intention techniques is more common in the SCC group, which is consistent with some studies that found that the techniques of closure most often used for reconstructing MMS defects are linear closures and flaps . However, these studies do not distinguish between BCC and SCC reconstruction.…”

Section: Discussionsupporting

confidence: 90%

“…NMSC encompasses basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), and other rarer malignancies such as atypical fibroxanthoma, Merkel cell carcinoma, porocarcinoma, and microcystic adnexal carcinoma. BCC is the tumor most frequently treated with MMS, and SCC is the second most common type of tumor treated with this technique …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma

et al. 2018

View full text Add to dashboard Cite

Background The two main tumors treated with Mohs micrographic surgery (MMS) are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). There are no studies analyzing whether MMS is different when treating these two types of tumors. Objective We aim to compare the characteristics of the patients, the tumors, and MMS, and first‐year follow‐up of MMS in BCC and SCC. Methods REGESMOHS is a prospective cohort study of patients treated with MMS. The participating centers are 19 Spanish hospitals where at least one MMS is performed per week. Data on characteristics of the patients, tumors, and surgery were recorded. The follow‐up was done with two visits: the first visit within 1 month after surgery and the second one within the first year. Results From July 2013 to April 2017, a total of 2,669 patients who underwent MMS were included in the registry. Of them, 2,448 (93%) were diagnosed with BCC, and 181 (7%) were diagnosed with SCC. Patients with SCC were older than those with BCC (median age 73 years vs. 68 years) and presented immunosuppression more frequently. The tumor size was significantly larger in the SCC group. Regarding surgery, deeper invasion was more frequent in SCC, resulting in larger defects. Despite this, SCC did not require more stages to get clear margins or more time in the operating room. Incomplete Mohs was more frequent in the SCC group (6%) than in the BCC group (2%). The incidence of perioperative complications was higher when treating SCC. There were more relapses in the first‐year follow‐up in the SCC group. Conclusion There are significant differences when comparing MMS in BCC and SCC. Knowledge of these differences can help to prepare the patient and plan the surgery, optimizing results.

show abstract

“…Most of the MMS series for NMSC show that 90–95% of the tumors treated with this procedure are BCC, whereas 5–10% are SCC . These data are consistent with our study.…”

Section: Discussionsupporting

confidence: 92%

Section: Discussionsupporting

confidence: 90%

See 1 more Smart Citation

Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Most published studies are retrospective and heterogeneous in terms of size, location or tumour histology. Therefore, it is difficult to conclude which alternative therapy would be most appropriate in each case of BCC, but MMS is considered the most appropriate treatment for tumours with high risk of recurrence based on criteria such as their location, size, symptoms, histology type, recurrences after previous treatments and immune status of the patient …”

Section: Discussionmentioning

confidence: 99%

Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence

Català

Alegre

Gich

et al. 2013

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…to reconstruct the resulting defect or to let the defect heal spontaneously, by second intention. [2][3][4][5] Although it is commonly believed that final defect size and anatomic location affect the type of repair selected, this has not been demonstrated. Additionally, it is unclear whether other patient-or physician-specific characteristics may affect the choice of reconstruction.…”

mentioning

confidence: 99%

Association Between Type of Reconstruction After Mohs Micrographic Surgery and Surgeon-, Patient-, and Tumor-Specific Features: A Cross-Sectional Study

Alam

Helenowksi

Cohen³

et al. 2013

Dermatologic Surgery

View full text Add to dashboard Cite

show abstract

Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs 2007)

Cited by 16 publications

References 17 publications

Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma

Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma

Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence

Association Between Type of Reconstruction After Mohs Micrographic Surgery and Surgeon-, Patient-, and Tumor-Specific Features: A Cross-Sectional Study

Contact Info

Product

Resources

About